(2R)-1-Benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide

Catalog No. :
ACCAYN408
CAS No. :
1254698-46-8
Molecular Formula :
C25H27N3O4
Molecular Weight :
433.51

IUPAC Name:(2R)-1-benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide

(2R)-1-Benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$271.00Login to see priceInquiryInquiry
5mg98%$657.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R)-1-Benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide
IUPAC Name(2R)-1-benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide
Molecular FormulaC25H27N3O4
Molecular Weight433.51
SMILESO=C(NC(CC1=CC=CC=C1)C(C(NC2CC2)=O)=O)[C@H]3CCC(N3CC4=CC=CC=C4)=O
InChI KeyMMLDHJRGTZHNHV-BPGUCPLFSA-N
SynonymSCHEMBL1613533 | 1254698-46-8 | Alicapistat | HY-109001 | ABT-957 | Alicapistat [INN] | BWF3F50KF8 | (2R)-1-Benzyl-N-((2RS)-4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl)-5-oxopyrrolidine-2-carboxamide | 1-benzyl-N-(4-(cyclopropylamino)-3,4-dioxo-1-ph
CAS No.1254698-46-8
PubChem CID67095330

Synthetic Route by SureRoute

1. ACCAYN408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCAYN408 route product structure diagram
    ACCAYN4081254698-46-8
Inquiry

2. ACCAYN408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIPRV968 route compound structure diagram
    ACIPRV96838854-94-3 In Stock
  4. Then
  5. ACCAYN408 route product structure diagram
    ACCAYN4081254698-46-8
Inquiry

Comments (0)